Muscular Dystrophy Treatment Market, By Product Type, Application - Industry Insights, Outlook, Opportunity Analysis, 2025

Muscular Dystrophy is characterized by a collection of muscle-wasting conditions. The disorder is caused by genetic mutations which interfere with the production of muscle protein dystrophin, necessary to build muscles. Muscular dystrophy is a genetic disease, consequently, the chance of an individual developing a disease increases with a history of muscular dystrophy in the family. The symptoms include shortening of muscles and tendons, the curvature of spine, weakening of heart muscles leading to cardiac problems, and breathing problems. The most common forms of muscular dystrophies include duchenne muscular dystrophy, becker muscular dystrophy, myotonic disease, congenital disease and oculopharyngeal muscular dystrophy. The cure for any form of muscular dystrophy is currently unspecified, but the symptoms can be relived through physical therapy, exercise, rehabilitative devices like a powered wheelchair, respiratory care and surgery.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/914

The common muscular dystrophy types:

1. Duchenne muscular dystrophy (DMD)

Most common form of muscular dystrophy in children caused by lack of protein dystrophin.    The onset of symptoms is seen at the age of 3, generally wheelchair-bound by 12. The Curvature in spine, heart, and lungs effects are the symptoms. Duchenne muscular dystrophy (DMD) is an X-linked disease predominantly affecting males, resulting in uniform muscle wasting. Death occurs due to respiratory failure by mid-twenties.

2. Becker muscular dystrophy(BMD)

Similar to Duchenne, however, with later onset and slow progression of the illness. Death occurs in the mid-forties.

3. Oculopharyngeal muscular dystrophy(OMD)

Initially affect eyelids, throat, and face followed by pelvis and shoulder. The onset of illness is seen between the ages 40 and 50.

4. Myotonic muscular dystrophy(MSD)

Most common form of muscular dystrophy in adults also called as Steinert's disease. Characterized by the inability of muscles to relax after contraction. Cataracts, insomnia, and arrhythmia are the symptoms.

5. Congenital muscular dystrophy (CMD)

The disease prevails from birth or before the age of 2. Significant impairment is caused by a swift progression of the disease. Congenital muscular dystrophy (CMD) causes learning disabilities and mental retardation.

Rising prevalence of muscular dystrophies with unspecific current medications is expected to fuel the muscular dystrophies treatment market

According to the research conducted by the Karger Journal on 2014, the global prevalence for muscular dystrophies accounted between 19.8 and 25.1 per 100,000 person every year with myotonic dystrophy (0.5-18.1 per 100,000), duchenne muscular dystrophy (1.7-4.2) and facioscapulohumeral muscular dystrophy (3.2-4.6 per 100,000) to be the most common types of disorders. The initial research phase of the therapies and ongoing clinical trials for the development of innovative products drives the global muscular dystrophy treatment market. Also, specific guidance for drug development for muscular dystrophy drugs published by the U.S. FDA in 2015 is expected to accelerate the new drug development for the treatment of a disorder. The emergence of disease-modifying therapies as a replacement for the unmet medical needs of patients who are not amenable to mutation-specific drugs is likely expected to fuel the revenue of the global muscular dystrophy treatment market in the forecast period. However, the fast prognosis of a disorder and low treatment seeking rate due to delayed diagnosis are the major limiting factors for the growth of global muscular dystrophy treatment market.

Molecular therapy segment is expected to generate larger revenue with higher efficiency in clinical trials

The global muscular dystrophy treatment market is segmented on the basis of treatment, diagnosis, end user and geography.

On the basis of treatment, the global muscular dystrophy treatment market is segmented into:

• Drugs
• Corticosteroids
• Angiotensin-Converting Enzyme (ACE) Inhibitors
• Physical Therapy
• Exercise
• Braces
• Mobility aids
• Breathing assistance
• Molecular Therapy
• Gene Replacement Therapy
• Stem Cell Research
• Protein Production Alteration
• Myoblast Transplantation

On the basis of diagnosis, the global muscular dystrophy treatment market is segmented into:

• Enzyme Assay
• Genetic Testing
• Electromyography
• Biopsy

On the basis of end user, the global muscular dystrophy treatment market is segmented into:

• Hospitals
• Home Care Settings
• Clinics
• Others

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/muscular-dystrophy-treatment-market-914

Specific guidance by FDA is expected to dominate North America the global market

Regional segmentation of the global muscular dystrophy treatment market by Coherent Market Insights comprises North America, Latin America, Europe, Asia-Pacific and The Middle East and Africa. According to the Centers for Disease Control and Prevention estimates in 2007, 349 out of 2.37 million males aged 5 to 24 years were reported to have duchenne muscular dystrophy or becker muscular dystrophy in the United States. North America is expected to dominate the global muscular dystrophy treatment market owing to the absence of marketed pharmacological therapies indicated to treat muscular dystrophy, rising prevalence of the disease and rising research and development for producing effective drugs. Europe is expected to boost the market share in the forecast period with the growing public awareness and increasing research activities. 

Launch of efficient corticosteroids to rise the market demand

The key players operating the global muscular dystrophy treatment market include Santhera Pharmaceuticals, PTC Therapeutics, BioMarin Pharmaceutical, Sarepta Therapeutics and Eli Lilly. The approval and launch of oral corticosteroid Emflaza in 2017, has been found highly effective in patients to regain strength and restore their ability to walk. The other vendors include Acceleron Pharma, Capricor Therapeutics, Bristol-Myers Squibb, Lexicon Pharmaceuticals, and Pfizer.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Dermatology Diagnostic Devices and Therapeutics Market, By Product Type, Application - Industry Insights, Outlook, Opportunity Analysis, 2025

Dermatology is the branch of science, which deals with skin and its appendages such as nails, hairs, sweet glands, and among others. Primary skin care and skin hygiene is the major concern of urbanization. Polluted environment leads to number of skin allergies and trigger various chronic diseases such as skin cancer. According to a study by Clinical Dermatology, in 2013, approximately 25% of the population suffers from skin ailments globally, out of which 15% of the population consult general physician with skin problem, wherein 1.2% refer to the dermatologist while rest are left unattended. It has also been stated that skin conditions are the fourth leading cause of nonfatal disease burden. Dermatology diagnostic devices and therapeutics market is the most dynamic and competitive market and is projected to retain same in the near future.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/933

Dermatology diagnostic devices and therapeutics market Taxonomy

By Product Type

Dermatoscopes

• Contact Oil Immersion Dermatoscopes
• Hybrid Dermatoscopes
• Cross-Polarized Dermatoscopes

Microscopes and Trichoscopes

• Multispectral Photoacaustic Microscope
• Raman Spectroscopy
• Reflectance Confocal Microscopy

Imaging Equipment

• X-ray
• Ultrasound
• Magnetic Resonance Imaging
• Optical Coherence Tomography

By Drug Class

• Antibacterial Agents
• Antifungal Agents
• Antiviral Agents
• Corticosteroids
• Retinoids
• Immunosuppressants
• Biologics

Rising prevalence of skin ailments and its impact is fueling the market growth

Dermatology diagnostic devices and therapeutic market is expected to increase, due to high prevalence of skin problem such as fungal infections, scabies, acne, psoriasis, and atopic eczema. According to a study by Global Burden of Disease (GBD), in 2010, fungal skin disease, subcutaneous disease, and acne are ranked among the top ten most prevalent diseases worldwide. The trajectory of the market depends on the rise of pollutants in the environment, drug patent expiry, over use of cosmetics, prevalence of chronic diseases, and increasing pool of children affected with skin ailments. Rising awareness about skin ailments and its treatment is a key factor augmenting the dermatology diagnostic device and therapeutic market growth. New and improved dermatology diagnostics products, for instance, in 2016 Sun Pharmaceutical Industries Ltd launched Suncros, a highly efficient product for all skin ailments, contributed largely towards the market growth.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/dermatology-diagnostic-devices-and-therapeutics-market-933

Regional Insight of the dermatology diagnostic devices and therapeutics market

Geographically, 33.2 % population of North America have significant skin ailments that deserve medical attention. According to the Journal of the American Academy of Dermatology, around 50 million people were affected with acne in North America in 2010, out of which 85% aged between 12 and 24, accounting to higher ratio in young population. In 2017, Food and Drug Administration (FDA) has approved a new product named Dupixent, which is used to treat atopic dermatitis, expected to propel the market growth in this region. According to a report by European Dermato-Epidemiology, in 2014, approximately 19% of the adults and 14% of children have skin diseases that need to be attended in Europe. This is mainly owing to high prevalence and high awareness of skin ailments, well-organized healthcare services, and reimbursement policies.

Latest launch and improved products is driving the Dermatology diagnostic devices and therapeutics market growth

Innovation of new and improved products in the market is expected to keep the market more competitive to combat with the latest product. For example, new product Dupixent approved by the U.S. FDA in 2017, is an injectable medication for the adult patients with moderate or acute eczema. This is mainly for the patients affected by the disease which cannot be controlled with prescription therapies used on skin (topically). Some of the major players operating in the global dermatology diagnostic devices and therapeutics market include Agfa-Gevaert N.V., Valeant Pharmaceuticals International, Inc., Cutera, Inc., Astellas Pharma, Inc., Galderma S.A., Novartis International AG., Dino-Lite Europe/IDCP B.V., Genentech, LEO Pharma A/S, Michelson Diagnostics Ltd, and Sun Pharmaceutical Industries Ltd.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Nurse Call System Market, By Product Type, Application - Industry Insights, Outlook, Opportunity Analysis, 2025

Nurse call system allows patients in health care settings to alert a nurse or any other health care staff, in case assistance is required. Some nurse care systems allow patients to speak directly to the staffer, some buzz at the station, while others simply beep, requiring a nurse to visit the patient’s room in order to determine the patient’s needs. Nurse call systems offer various benefits to patients who are confined to the hospital bed and have no other way to communicate or alert the nurse, in case any assistance is required. Such as system thus, provides increased sense of security to patients.

Furthermore, there are various types of nurse call system such as wireless nurse call, intercoms, cell phone alert, and the basic system that has nothing more than a button. Increasing home healthcare and nursing home facilities are expected to favor growth of the nurse call system market. Moreover, increasing demand for responsive and efficient healthcare communication is expected to propel growth of the nurse call system market.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/955

Nurse Call System Market Taxonomy

By Equipment Type

• Nurse Call Intercoms
• Nurse Call Buttons
• Nurse Call Integrated Communication Systems
• Nurse Call Mobile Systems

By Communication Technology

• Wireless Communication Equipment
• Wired Communication Equipment

By End User

• Hospitals
• Ambulatory Care Services
• Clinics
• Assisted Living Centers

Increase in number of patients in hospitals is expected to fuel the growth of nurse call system market

Nurse call system creates highly reliable and flexible communication between a patient and nurse. Increasing number of patients in healthcare facilities and adoption of the new and better ways to scale the communication, workflow, and management in order to achieve quality patient care are expected to support growth of the nurse call system market in the near future. According to Centers for Disease Control and Prevention, around 7.6% of people in the U.S. were recorded to have stayed overnight at hospitals in 2015, which indicates high demand for nurse call system in hospitals, as patients could require assistance at any time. Moreover, increasing hospitalization of geriatric population is expected to favor growth of the nurse call system market, as rate of fractures and other injuries were recorded to be higher for adults aged 85 years and above in the U.S., according to Centers for Disease Control and Prevention, in 2015.

Regional growth engines that support nurse call system market

On the basis of geography, the nurse call system market is segmented into North America, Europe, Latin America, Asia Pacific, Middle East, and Africa. North America is expected to witness rapid growth due to increasing number of regulatory reforms, change in reimbursement policy and also increased amount of funds received to update the hospital technology to make it more reliable and efficient for patients. Growing geriatric population in Asia Pacific, includes the older population that is unable to perform their activities independently, requiring assistance. This in turn, is expected to create favorable environment for growth of the nurse call system market in Asia Pacific in the near future. Furthermore, Europe is also expected to witness rapid growth due to rise in government funds and establishment of separate nursing technologies in the region. For instance, in October 2012, Prime Minister of the U.K. announced the establishment of nursing technology fund to support nurse service for safe and more efficient and effective care.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/nurse-call-system-market-955

The Prominent Key Players in the Nurse Call System Market

Manufactures are in the process of innovating nurse call system with better mobility and data integration. The key players operating in the nurse call systems market include Hill-Rom Holdings, Inc., Tyco International PLC, Ascom Holding AG (Switzerland), Rauland-Borg Corporation, and Honeywell International, Inc.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Wearable Injector Market, By Product Type, Application - Industry Insights, Outlook, Opportunity Analysis, 2025

Drugs are mostly viscous and has various formulations (intravenous, intramuscular, and subcutaneous) that needs to be absorbed into digestive tract, which raise multiple drug delivery issue with traditional drug delivery system. Moreover, such issues not only raise costs but also decrease satisfaction and compliance of patients. Wearable injectors or bolus injectors are the new class for drug delivery device designed for subcutaneous delivery. It has capacity to hold the drug volume of up to 2.5 ml. Wearable injectors are easy to handle, low cost, disposable, and allow self-administration. Advancement in injector technology over traditional drug delivery system include single button to release the drug and after completion of drug in body, the needle is retracted and gets locked automatically. Thus, it’s safe and convenient disposable system benefits people who has needle phobia. Furthermore, it allows audible and visual signals, which is expected to fuel the growth of wearable injector market during forecast period.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/970

Strategies to improve drug delivery system through the introduction of new wearable injectors is expected to propel the growth of wearable injector market

In 2015, Unilife Corporation introduced Imperium, which is an instant patch pump used for insulin. Imperium is a subcutaneous insulin infusion, disposable, prefilled, and multi-day wearable insulin pump. It has various features that include data connectivity for app to constantly remind and update wireless connectivity such as Bluetooth LE. It also provide real-time access to healthcare provider to track the insulin therapy of each patient.

In 2014, Enable Injections LLC has signed an agreement with CSL Behring to develop novel drug delivery devices. Enable Injectors intent to improve comfort, convenience, and compliance administrative device for the patients with rare diseases.

Enable Injection LLC and Flex entered in agreement to develop and manufacture wearable medical device in 2016. Enable and Flex aims to develop subcutaneous pain-free injection technology with features such as Bluetooth connectivity, monitoring system with smartphone app, mix automation, and passive warming system.

Unilife Corporation entered in an agreement with Amgen to develop customized wearable injectors in 2016. Unilife has granted exclusive rights to Amgen for Unilife’s wearable injectors, with only selected drug classes are used for wearable injector device. Furthermore, Unilife also granted some non-exclusive rights to Amgen for its delivery system of certain therapeutic area that include inflammation, nephrology, oncology, bone health, neuroscience, and cardiovascular.

Increasing prevalence of chronic diseases and high demand for advanced drug delivery device for frequent administration of drug is expected to augment the market growth

According to the World Health Organization (WHO), around 1.6 million deaths caused by diabetes in 2015 and is expected to increase by more than 50% before the age of 70 years by 2030. Moreover, According to National Institute of Health (NIH), in 2017, around 23.5 million people are suffering from autoimmune diseases in U.S.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/wearable-injector-market-970

According to World Health Organization (WHO), in 2017, nearly 1 in every 6 death occurs due to cancer globally and approximately 70% of deaths from cancer occur in low and middle-income countries. Increasing prevalence of chronic disease and high demand for advanced drug delivery devices for frequent administration of drugs is expected to fuel the growth of wearable injector market during the forecast period.

Some of the key players operating in the global wearable injector market include Medtronic Plc, West Pharmaceutical Services, Inc., Enable Injections, F. Hoffmann-La Roche Ltd, scPharmaceuticals, Inc, Johnson & Johnson, Insulet Corporation, Sensile Medical Ag, Becton, and Dickinson And Company.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Healthcare Cloud Computing Market, By Product Type, Application - Industry Insights, Outlook, Opportunity Analysis, 2025

Cloud computing, often referred to as ‘the cloud’, is a method to store and access the data and programs over the internet. The cloud computing is the delivery of computing resources over the internet on a pay-for-use basis. The resources which are used are elastic and the user pay for the services procured. Cloud computing helps the healthcare industry in numerous ways such as it allows professionals to store and access data remotely, it provides the great reach during the times of disaster so that the professionals can reach to the required places, it provides and holds more information at a lower cost, and clouding helps to share and store data, which helps to speed up the medical research.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/944

Numerous applications of cloud computing for healthcare data management is the factor driving the healthcare cloud computing market

Individuals maintain their health by using smartphones and wearables so that they can track their diets, exercise records and vital signs, and to review doctors and care facilities. This growing consumer participation is the major driving factor of healthcare cloud computing market. Some essential requirements such as security, confidentiality, privacy, traceability of access, reversibility of data, interoperability included in healthcare data management  is possible with the use of cloud computing. The need of  legislation of healthcare data compliance policies, rise in interest of load balancing benefits  , and the growing of bring –your- own –device (BYOD) strategy at hospitals ,  are some of the factors leading to the growth of healthcare cloud computing market. According to Health Information and Management Systems Society (HIMSS), 83% of healthcare organizations are using cloud based apps today, and 53% of healthcare employees are using three or more devices for work. Additionally, cloud computing offers big data sets for radiology images, electronic health records, and genomic data offloading, contributing to the growth of healthcare cloud computing market. However issues related to interoperability and standardization of cloud and growing concern related to patient information security are some restraints that are likely to hinder the growth of healthcare cloud computing market.

Greater advantages of software as a Service (SaaS) model is more used by healthcare industry, adding to the revenue of healthcare cloud computing market

The global healthcare cloud computing market is segmented by applications, by service model, by deployment model, by pricing model, by component and by region.

On the basis of applications, the healthcare cloud computing market is segmented into

• Non –Clinical
• Clinical

On the basis of service model, healthcare cloud computing market is segmented into

• Information service
• Platform service
• Software service

On the basis of deployment- model, healthcare cloud computing market is segmented into

• Public- cloud deployment model
• Private- cloud deployment model
• Hybrid -cloud deployment model

North America dominates in the healthcare cloud computing market owing to established healthcare and IT sector

Regional segmentation of healthcare cloud computing market by Coherent Market Insights comprises of North America, Latin America, Europe, Africa, Asia Pacific, and Middle East. Widespread use of digital recordkeeping systems is helping North America to dominate in the healthcare cloud computing market. North America is the traditional hub for the intensive research in the healthcare industry as well as in the IT industry, contributing to the growth of healthcare cloud computing market in this region.

The advantages of cloud computing services is helping the companies to operate easily in highly fragmented healthcare cloud computing market

Key industry players operating the healthcare cloud computing market includes ClearData Networks, CareCloud Corporation, AthenaHealth Incorporated, CareStream Health Inc., Dell Incorporated, GNAX Health, IBM Co., Merge Healthcare Incorporated, VMware Incorporated, and Iron Mountain Inc. Healthcare cloud computing market is highly competitive but advantage of cloud computing of being easy to scale up and scale down making use of these services lucrative for companies operating in healthcare cloud computing market. The industry players are adopting the strategies such as client acquisitions, partnerships, alliances, event participation, educational promotion and others to sustain in the healthcare cloud computing market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Medical Nutrition Market, By Product Type, Application - Industry Insights, Outlook, Opportunity Analysis, 2025

Medical nutrition is the therapeutic nutritional supplements prescribed to fulfill specific nutritional needs of the patient. It is used as part of treatment of various diseases and disorders such as diabetes, Parkinson’s disease, cancer, gastrointestinal disorder, malnutrition, and immune system disorder. Nutrients play vital role in the biochemical process of the body. In order to make the body function optimally, nutrition content should be available to body in sufficient quantity, and in the right form. Nutrients comprise vitamins and minerals. Nutrients are obtained through the diet and through the processes within the body, including the action of the gut bacteria. However, during stress or diseased condition, these nutrients may not be absorbed by the body through regular diet. Medical nutrition helps address these specific needs of the body.

Tailored Information as per niche requirement: https://www.coherentmarketinsights.com/insight/request-sample/925

Rise in the prevalence of chronic diseases globally expected to boost the medical nutrition market

The major factors contributing to the growth of medical nutrition market are rising incidence of diseases such as cancer. Medicine and nutritional therapy is recommended to the cancer patient in order to combat with the weak immune system, which affects eating habit resulting into drastic weight loss in a patient. Increasing rate of chronic diseases, such as chronic obstructive pulmonary disease is leading to the incensing number of malnutrition, which is expected to drive the medical nutrition market globally. According to World Health Organization (WHO) in 2015, around 3 million patients died due to obstructive pulmonary disease. Factors driving the growth of medical nutrition market include changing lifestyles and rising awareness among the population related to the advantages of medicated food and beverages. The factors hindering the growth of medical nutrition market are stringent regulations by Food and Drug Administration (FDA), such as maintaining the good manufacturing practices by the manufacturers to ensure product quality. FDA maintains the safety and quality standards based on scientific principles, strict medical evaluation, and supervision.

Medical Nutrition Market Taxonomy

Medical nutrition market is segmented on the basis of product type, application, and Geography

On the basis of product type, the medical nutrition market is segmented into:

• Elderly Nutrition
• Parenteral Nutrition
• Pediatric Nutrition
• Sports Nutrition

On the basis of application, the medical nutrition market is segmented into:

• Diabetes
• Obesity
• Sarcopenia
• Cancer
• Others

Increasing incidences of malnutrition is expected to propel the growth of medical nutrition market in the North America region

On the basis of geography, the medical nutrition market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. North America is the largest region for medical nutrition market globally followed by Europe. Rising prevalence of malnutrition has propelled the growth of medical nutrition market in the North America region. According to the Feeding America 2015, around 2 million people suffer from starvation in the U.S, including 13 million children. Asia Pacific is expected to be the dominant region for medical nutrition market over the forecast period and the factors responsible for increasing number of diseases, such as diabetes, cancer, and others.

To know the latest trends and insights prevalent in Medical Nutrition Market click the link below: https://www.coherentmarketinsights.com/ongoing-insight/medical-nutrition-market-925

The innovative Neocate Syneo launched by nutrica in pediatric nutrition business to boost the medical nutrition market.

Key players operating the medical nutrition market include Baxter Healthcare, Abbott Healthcare, Fresenius kabi, B Braun Melsungen Ag, Nestle health sciences, and Nutrica. Nutrica has launched an innovative Neocate Syneo in 2016, a unique blend of probiotics and prebiotics, which is considered to support the development of a balanced gut microbiota in infants suffering from numerous food allergies, milk allergy, and related gastrointestinal conditions. Neocate syneo is the first hypoallergenic formula launched in pediatric nutrition business.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Medical Tourism Market by treatment type, Geography - Industry Insights, Trends, Outlook, And Opportunity Analysis, 2017-2025

Medical tourism refers to people living in one country travelling to another country so as to acquire a particular medical treatment. This tourism is mostly motivated due to the unavailability, cost difference, quality difference or illegal practices of a particular treatment in one’s own country.. The conventional medical tourism involved people living in developing countries travelling to developed countries so as to get high end treatments that were usually not available in their own country. However, with the recently changing scenario of medical tourism, people from certain developed countries are also travelling to developing countries mainly due to the affordability of these treatments in the developing countries as compared to that of the developed ones. Certain treatments are also not legally practiced in few countries leading to the migration of population interested in the treatment to travel to some other places so as to receive the treatment of medical procedure. Domestic medical tourism involves people travelling between different cities of the same country. This mainly involves surgical processes or similar treatments related to cosmetology or similar streams. Although, people are also indulged into dental and fertility tourism these days. Apart from the common treatments, the medical tourism services is available in all the fields of healthcare including psychiatry, convalescent care, burial services, and alternative medicines.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/938

Medical tourism as one of the fastest growing market of the healthcare sector

The Nerd Wallet Health analyzed the data from the Centers for Disease Control and Prevention (CDC), U.S. census and Federal Court System in 2013 and came up with the facts suggesting that around 56 million Americans under the age of 65 years have trouble paying their medical bills. Additionally, over 25 million adults ranging from 19-64 years do not take their prescribed drugs, take less medicine than suggested or are involved in dose skipping practices for cost saving purposes. As per the Health-Tourism fact sheet and statistics, the medical tourism has generated a massive revenues between US$ 60,000 to US$ 70,000 in 2015 and expected to show almost double growth in a couple of years. These suggest the fast growing and expansion of the global medical tourism market giving an idea to the upcoming players of the market.

The global medical tourism market is segmented on the basis of the treatment type and geography.

On the basis of treatment type, the global medical tourism market is segmented as

• Cardiovascular Treatment
• Orthopedic Treatment
• Neurological Treatment
• Cancer Treatment
• Fertility Treatment
• Other General Treatments

India considered to be the hotspot and most preferred destination for medical tourists across the globe

Based on the regional segmentation, the global medical tourism market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East and Africa. Asia Pacific is currently attracting the major flow of patients from the U.S. and Europe by offering quality services at affordable prices. According to a report by ZAWYA, Dubai is reported to have raised US$ 381 million from medical tourism, accounting up to 326,649 tourists visiting the Emirates in 2016. According to the VOA News, Turkey is the major destination for hair transplantation with over 152,000 visits in 2016 delivering safe, cheap and high-quality services. Moreover, India is known to be the hot spot for medical tourism attributing to the presence of highly skilled doctors and improved medical infrastructure offering affordable cardiovascular, orthopedic, and cancer treatments at about 20%-30% less as compared to standard U.S. costs. Thus Asian countries such as India, Thailand, Singapore, Malaysia, South Korea and Turkey offer major destinations for medical tourism to the people around the world.

Affordability without quality compromise resulting in influx of huge population in various countries fueling the global medical tourism market

The lack of medical insurance is the primary reason driving the growth of global medical tourism market. With the broadening of internet facilities in the rural areas, it has been possible to help the patients to identify different destinations providing specialized treatments and low prices with the help of online advertisements. The respective governments are also assistive and supportive towards the medical tourism in the country by offering several visa policies to the patients and their companions. For instance, the liberal e- Visa policy by Indian government will boost the medical tourism of India with rising footsteps in the country opting solid organ transplants, cardiovascular treatments, orthopedic and cancer facilities at about 65%-90% cheaper to that of the U.S. prices as stated by an article published in Business Standard in 2016. However, the inability to deliver post- surgical care by the hospitals and the visa restrictions could hamper the market growth.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/medical-tourism-market-938

Key players involved in medical tourism market are Asian Heart Association, Apollo Hospitals, Prince Court Medical Centre, Gleneagles Hospitals, Min-Sheng General Hospital, Raffles Medical Group, Bangkok Hospital, Fortis Healthcare Ltd., Anadolu Medical Centre, and Wooridul Spine Hospital.

Mediating agencies providing scope for expansion to the medical tourism market

Several private agencies offering medical tours worldwide includes France Surgery, MediCzech, Professional Beauty, ClinicAccess, BB Health Solutions, Revitalize in Turkey, Euromedical Tours, Doctour, Celsus Medical, and InLife. Certain private agencies also provide medical tourism facilities such as Medical Tourism Association which is a first non- profit organization created in the medical tourism industry. The government mediating agencies and brokers such as Joint Commission International (JCI) have assisted a number of patients by giving them relevant and necessary information about the presence of these services that results in the influx of patients towards other countries for better treatment options.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Biobank Market by product type, and end-user - Global Industry Insights, Size, Share, Trends, 2025

Biobank is a type of repository which collects and store biological samples for biomedical research. The human biological materials include blood, purified DNA, saliva, serum, and other specimens. Preservation of cells and tissues samples is done by cryopreservation at -1960C or using chemicals. The biobanks keep a health related records of genetic information, lifestyle, and family history. Biobank help researchers to detect human diseases and their unspecified causes by conducting various tests on the samples. Biobanks are largely used to access variety of data representing a large number of people for providing personalized medications, minimizing drug reactions, stem cell research, updating age demographic databases. The bio-repositories play a fundamental role in research and development, which is associated with drug development and discovery. Biobanks also provide inevitable assistance in gaining prospective to orphan diseases associated with genome wide studies via single nucleotide polymorphism (SNP).

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/896

Development of personalized medicine to develop effective therapies drives the global biobank market

Poor productivity rate of the pharmaceutical industry with 90% failure of proposed drugs during clinical trials, the adherence of human tissue samples, and stem cells to execute pre-clinical trials for reducing high cost associated drug failures are the factors expected to drive the growth of biobank market. Additionally, novelty in cell and tissue disorder treatments, drug discovery, rising incidence of chronic diseases and government initiatives for innovation of regenerative medicines are the key factors driving the global biobank market. The extensive development of personalized treatments by research organizations to develop effective therapies to satisfy medical needs using biological samples is expected to fuel the demand for biobank market during the forecast period. For instance, Illumina signed 4 biobank deals in 2016, with Partners HealthCare, Montreal Heart Institute, University of Colorado and Vanderbilt University with an objective to improve healthcare and develop personalized medicines. However, cost competitive techniques, tissue injury during freezing, reimbursement concerns, lack of standardization, confidentiality and surveillance issues, economic downturn, and ethical issues are the major factors restraining the growth for global biobank market.

Establishment of drug efficacy contributes to the dominance of target tissue segment

The global biobank market is segmented on the basis of bio preservation media types, products, analysis, applications, end user and geography.

On the basis of bio preservation media types, the global biobank market is segmented into:

• Optimized Pre-Formulated Media
• Non-Optimized Isotonic Formulation Media

On the basis of products, the global biobank market is segmented into:

• Consumables
• Equipment
• Refrigerators and Ice Machines
• Liquid Nitrogen Supply Tanks
• Cryogenic Storage Systems

On the basis of analysis, the global biobank market is segmented into:

• Human tissue and tumor cells
• Bio-fluids
• Stem cells
• Umbilical cord
• DNA/RNA

Tailored Information as per niche requirement: https://www.coherentmarketinsights.com/insight/request-customization/896

On the basis of application, the global biobank market is segmented into:

• Biobanking
• Regenerative Medicine
• Drug Discovery

On the basis of end-user, the global biobank market is segmented into:

• Diagnostic Clinical Centers
• Research Organizations
• Others

Increasing funds from National Institute of Health, USA is expected to dominate North America in the global biobank market

Regional segmentation of the global biobank market by Coherent Market Insights comprises North America, Latin America, Europe, and Asia-Pacific. According to the research conducted by BioMed Central, United States, stored 270 million specimens in biobanks in 2008, with the rate of new samples collected being 20 million every year. North America is expected to dominate the global biobank market with the increasing funds from healthcare organizations like National Institute of Health (NIH) and National Cancer Institute, which facilitate biobanks across the U.S. Additionally, the rising interest in biotechology has facilitated collaborations of biobanks which is expected to augment the global biobank market in the forecast period. Asia-Pacific is expected to have an opportunistic biobank market owing to the rise in diseases, government initiative to finance the cell-based therapies, substantial investment by pharmaceutical, high number of biotechnology companies, and public awareness.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/biobank-market-896

Automation of storage processes is the latest trend adopted by the key players

Key players operating the global biobank market includes Thermo Fisher Scientific Inc., BioLife Solutions, Inc., Beckman Coulter, Inc., Panasonic Biomedical Sales and Tecan AG. New product launches, increasing collaborations, mergers and acquisitions and partnerships among the market players are some of the strategies observed in global biobanks market. Biomatrica, IntegenX, radiofrequency identification, and micro electromechanical systems are the innovative reagents and products launched for the storage and stabilization of DNA and RNA at room temperature. The other companies operating in the global biobank market are BioCision, Taylor-Wharton International, VWR International and So-Low Environmental Equipment Co. among others.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Lab-On-a-Chip Market by product type, and end-user - Global Industry Insights, Size, Share, Trends, 2025

A lab-on-a-chip (LOC) is a device that incorporates one or several laboratory functions on a single integrated circuit whose size varies from few millimeters to limited square centimeters to achieve automation and throughput screening process. Lab-on-a-chip devices can hold up to a small amount of fluid having volume less than Pico liters. Furthermore, such devices are the part of micro electro mechanical systems (MEMS), which is also known as micro total analysis system (µTAS). Lab-on-a-chip devices allow laboratory synthesis or chemical analysis on a very small scale that have recently shown significant benefits and potential for a wide range of applications such as genomic research, proteomics research, analytical chemistry, environmental monitoring, the point of care diagnostics, and biohazards detection. LOC devices reduces the use of reagents and sample consumption, which reduces the result output time. LOC devices are small in size, portable, cost effective in manufacturing and requires less power as compared to conventional lab devices. These are the few factors, which are expected to fuel the growth of the lab-on-a-chip market.

Tailored Information as per niche requirement: https://www.coherentmarketinsights.com/insight/request-sample/515

Lab-on-a-chip market taxonomy:

By Application

• Genomics
• Proteomics
• Diagnostics
• Drug Discovery

By Product

• Reagents and Consumables
• Software
• Instruments

By End-User

• Hospitals
• Diagnostic Labs
• Academic and Research Institutes
• Home Care
• Biotechnology and Pharmaceutical Companies

By Technology

• Microarrays
• Microfluidics

Wide range of application and advance technology fuels the growth of lab-on-a-chip market

Lab-on-a-chip devices are used for various purposes such as analytical chemistry and diagnostics but they are majorly used in diagnostic and life-science research. The utilization of the device is significantly depends on the epidemiological factors globally. For instance, there is an increase in infectious diseases such as HIV, tuberculosis, measles and malaria. As per The Joint United Nations Programme on HIV/AIDS (UNAIDS) there are around 36 million people infected from HIV/AIDS globally. Also, there is observable rise in peripheral vascular disorders such as claudication, arteriosclerosis obliterans and intermittent claudication. Furthermore, with an increase in healthcare investment the market growth of LOC devices is expected to gain traction in the near future.

In 2016, according to Centers for Disease Control and Prevention (CDC), in the U.S. 12-20% of the population aged age 60 and above are diagnosed with the peripheral vascular disease every year, which is approximately 8.5 million. There is a significant increase in geriatric population that supports the growth in lab-on-a-chip market as according to World Health Organization (W.H.O) it is expected that in near future geriatric population will double. According to National Institute of Aging, in 2016 there are around 620 million people globally are above the age of 65 and is expected to grow to 1.6 billion by 2050. Moreover, the increase in personalized medicine and cancer research will lead to the increase in the lab-on-a-chip market in the near future with many of the further supporting factors of the devices such as user friendly approach, easily portable and wide use in hospitals and surgical centers supports. Increasing use of conventional laboratory equipment is the major challenge that is expected to slow down the pace in awareness of the device by healthcare experts. Lab-on-a-chip technology is projected to get commercialized gradually however, in near future, this technology is expected to play a major role in the life-science industry.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/lab-on-a-chip-market-515

Developed regions are major growth engine of lab-on-a-chip market

The globally lab-on-a-chip market is segmented into North America. Latin America, Europe, Asia-Pacific, Middle East and Africa. North America is leading the market in terms of increase in geriatric population, research, advancement in technology and wide acceptance of the lab-on-a-chip technology. According to Population Reference Bureau, in 2016 there were around 40 million people in U.S. above 65 and over and it is expected to reach 19 million by 2050. Europe is the second largest region in the lab-on-a-chip market due to the region being an early adopter of advanced technologies. Asia Pacific is the fastest emerging region due to a large population and unmet clinical needs of people. According to Economic and Social Commission for Asia and the Pacific, in 2016, there are around 4.5 billion people in Asia Pacific.

Key players to support the growth of lab-on-a-chip market

Takra Bio Inc., Nobel Biocare Services AG, Bio-Rad Laboratories Inc., PerkinElmer Inc., and Cepheid Inc., are among the major players in the lab-on-a-chip market.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Insulin Pumps Market by product type, and end-user - Global Industry Insights, Size, Share, Trends, 2025

Insulin pump is a portable device attached to the body that continuously delivers preset amounts of short or rapid acting insulin in the body to control diabetes. Insulin therapy is required in type 1 diabetes and sometime in type 2 diabetes. It serves as an effective alternative to insulin injections. Furthermore, insulin pump delivers the insulin according to the need of body as basal rate, where small amount of insulin is delivered continuously whole day for maintaining normal function of body that is programmed by health care professionals and as bolus dose, which is the additional dose of insulin required according to the food supply to correct the blood sugar level of the body. Insulin pump consists of main pump unit that holds insulin reservoir i.e. 176-300 units of insulin. There are various types of insulin used to treat diabetes that includes rapid, short, intermediate and long acting insulin.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/416

The essential factors driving the growth of this market is diabetes, awareness of diabetes, type of insulin and different methods to deliver insulin. Insulin pump device are small and durable. Insulin pumps are user friendly, as they can be programmed easily and LCD screen is available for display of programs. Battery compartment and reservoir compartment is also compact. Insulin pump provides more flexibility to lifestyle as it is highly portable. Number of injection are also reduced due insulin pumps. Whereas there is precise delivery of insulin to gain better control on diabetes.

Insulin pump market taxonomy

Product Type

• Traditional insulin pumps
• Disposable insulin pumps
• Smart pumps

End Users

• Hospital
• Clinics
• Home Care
• Laboratories

Rising number of diabetes to fuel the growth of insulin pump market in the near future:

According to Lancet study 2016, there was four fold increase in number of diabetes 108 million in 1980 to 422 million in 2014 and half of them live in India, China, U.S., Brazil, and Indonesia. Rise in number of diabetic patient globally is expected to favor growth of the insulin pump market in the near future. There are two types of diabetes type 1 and type 2. In type 1 diabetes, immune systems destroys the cells in pancreas called as beta cells which are responsible for insulin production. So externally manufactured insulin needs to be provided by insulin pump to recover a person from diabetes which in turn is expected to favor the insulin pump market in the near future. In type 2 diabetes body does not use insulin properly it is also called as insulin resistance. So type 2 diabetes patient need to take multiple shots of insulin which is provided by insulin pump as it is designed to deliver continuous amount of insulin 24 hrs. According to findings of various studies in 2015, insulin pump is a safe and valuable treatment option for diabetes. Other advantage of the insulin pump is that it frees you from having to measure insulin into a syringe. According to WHO the number of people with diabetes has risen from 108 million in 1980 to 422 million in 2014.  Which is further projects to favor growth of the insulin pump market in the near future. The above reasons are projected to provide significant traction in the growth of insulin pump market over the forecast period.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/insulin-pumps-market-416

Diabetes prevalence has been rising more rapidly in middle- and low-income countries that is expected to support the growth in insulin pumps market

The International Diabetes Federation estimated that 8.3% (382 million) of adults globally had diabetes in 2013 and that the prevalence vary across different countries.  According to American diabetes Association age- and sex-adjusted diabetes prevalence were highest in the poorer countries and lowest in the wealthiest countries. LIC (Bangladesh, India, Pakistan, and Zimbabwe) 14.0%, LMIC (China, Colombia, and Iran, Palestine) 10.1%, UMIC (Argentina, Brazil, Chile, Malaysia, Poland, South Africa, and Turkey) 10.9%, and HIC (Canada, Sweden, and the United Arab Emirates) 5.6% Differences between countries may be the because of differences in the distributions of risk factors among countries, such as family history of diabetes, age, obesity, socioeconomic status, birth weight,  ethnicity, and the degree of westernization. This augments growth of the insulin pump market more in middle- and low-income countries.

Major acquisitions to support growth of insulin pump market.

Medtronic Integrated performance report sales increased from US$15,000 in 20212 to US$ 30,000 in 2016. Key players operating in insulin pump market include Medtronics, Braun Melsungen Abbott Laboratories, Becton, Dickinson and Company, Sanofi, Insulet Corporation, and Hoffmann-La Roche AG.

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Bronchoscopes Market by product type, application, end-user - Trends, Outlook, and Opportunity Analysis, 2017–2025

Bronchoscopes is an endoscopic technique used for diagnostic and therapeutic process to study the inner pathways of lungs. Bronchoscopes are the devices that are introduced from the mouth or nose and occasionally through tracheostomy to observe distal branches of the bronchi. Furthermore, bronchoscopes are commonly used to diagnose tumors, infection, inflammation, foreign bodies, lung bleeding, and parasites. Bronchoscopes are classified into two forms named as rigid and flexible on the basis of their designs. Rigid bronchoscopes employ metal parts, which allows them to remove foreign bodies while flexible bronchoscopes design allow greater entrance as they employ flexible optical cables that enables real time video recording. The flexible bronchoscope flexibility tends till 180 degree allowing great maneuverability. However, depending upon the nature of medical conditions, major types of bronchoscopes have their respective advantages.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/421

Medical conditions where support is required, rigid designed bronchoscope were used for example tracheal wall collapses, aspiration, removal of foreign body, electron cauterization and so on. On the other hand rigid bronchoscopes are more prone to cause tissue damage and also side effects like damaged vocal cord systems, pneumothorax and others. Flexible bronchoscopes can reach easily to deep alveoli sacs medical conditions such as biopsy, suctioning, laser resection of tumors, cauterization can be performed using flexible bronchoscopes. Cost wise, rigid bronchoscopes are much competent to flexible versions as flexible bronchoscopes are high in cost however they are in significant use due to its better efficiency in terms of applicability and versatility.

Bronchoscopes market taxonomy:

By Product Type

• Rigid Bronchoscopes
• Flexible Bronchoscopes

By application

• Bronchial diagnosis
• Bronchial treatment

By End User

• Hospitals & Clinics
• Ambulatory Surgical Centers (ASCs)

Bronchoscopes devices is being fuelled by rising incidence of diseases

Bronchoscopes is a valuable tool for evaluation and management of airway disease. It is used to evaluate various bronchopulmonary diseases including tumors, chronic obstructive pulmonary diseases, airway foreign bodies, bronchopulmonary hemorrhage, and airway stenosis, infectious and inflammatory conditions. Bronchoscopes can be used to find the cause of airway problems, such as airway bleeding, trouble in breathing, or a long-term cough. Blockage created in the airway or narrowed airways can also be removed using bronchoscopes. Bronchoscopes are used to treat cancer of the airway using radioactive materials. Bronchoscopes are also used to take tissue sample when other tests, such as CT scan or X-ray show problem with lung or with lymph nodes in chest. Lung diseases such as chronic obstructive pulmonary diseases (COPD) sinusitis and otitis media are diagnosed by collecting tissue or mucus samples for examination the extent of diseases is also analyzed using bronchoscopes. According to WHO, it is estimated that around 3 million deaths were reported worldwide due to COPD in 2015.

Growth engines for bronchoscopes market

Most populated and urbanized regions such as North America, Asia pacific and European region in world that uses the medical advances for treatment purpose shows the largest bronchoscopes market. The high growth in India and China can be attributed to government and venture capital investments in China in the field of bronchoscopes, bronchoscopes research support in Japan (WABIP), and increasing number of bronchoscopes surgeries & improving bronchoscopes infrastructure in India. According to Centers for Disease Control and Prevention (CDC) 212,584 people in the U.S. were diagnosed with lung cancer in 2013. Furthermore, W.H.O shows highest lung cancer mortality rate (per 10,000) in 2012 were 47.6 in Central and Eastern Europe which augments growth of the bronchoscopes market.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/bronchoscopes-market-421

Major acquisitions to support growth of bronchoscopes market

The World Association for Bronchology and Interventional Pulmonology (WABIP) organization consists of over 7,200 medical professionals representing over 50 regional professional representation and national societies that is expected to favor growth of bronchoscopes market. Key players operating in bronchoscopes market include Olympus Corporation, Fujifilm Holdings Corporation, and PENTAX Medical Company. 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Balloon Catheters Market, By, Geography - Opportunity Analysis, and Industry Forecast till 2025

The balloon catheter is a flexible, tubular device with a balloon at its tip that is used to create, enlarge or remove blockage of a passageway within the body, by passing it through body channels. The balloon tip can be expanded by water or air to remove the blockage or to expand partly closed passageway during procedure. The balloon catheter used to treat heart related disease specifically coronary heart disease, which are caused due to diabetes, high blood pressure and high cholesterol level in blood. During the treatment of coronary heart disease, the balloon catheter helps to allow the blood flow from arteries by making a passageway that is blocked due to excess cholesterol by avoiding open heart surgery.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/489

Also, the balloon catheter plays major role in angioplasty to treat atherosclerosis by widening the narrowed or obstructed arteries or veins. As, the procedure is minimally invasive, it is economically beneficial to the patient and helps patient to get cure rapidly as compared to open surgical procedure.

Market Dynamics

Rising incidence of cardiovascular disease and coronary heart disease cases due to increase in the prevalence of diabetes, high blood pressure cases and number of smokers worldwide is expected to favor the demand for balloon catheters around the globe.

According to World Health Organization (WHO), in 2015 around 17.7 million people died due to cardiovascular disease worldwide, and out of this total deaths around 7.4 million were die due to coronary heart disease. Furthermore, the majority of deaths are occurred in emerging economies due to high prevalence rate and lack of healthcare services in rural areas.

Also, increasing aging population and rising demand for minimally invasive procedures are the other factors leading to the growth of balloon catheters market in developed as well as emerging economies.

As per United Nations Population Fund, people aged 60 years and above accounted for 12.3% of the global population in 2015, which is expected to increase to 22% by 2050. The factors behind aging population in developed region are developed healthcare services and access of healthcare facilities to people, better nutrition, sanitation and economic development.

Browse Research Report At: https://www.coherentmarketinsights.com/market-insight/balloon-catheters-market-489

Market Taxonomy

This report segments the global balloon catheters market on the basis of product material and geography. On the basis of material, the market is categorized into polyurethane, nylon and other type of materials such as pebax. Among these, the polyurethane segment dominate the balloon catheters market throughout the forecast period. On the basis of geography, the market is divided into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa. Among all regions, North America contributes major market share supported by increased incidence rate of cardiovascular disease and growing inclination of the populace towards minimally invasive procedures.

Key features of the study:

• This report provides in-depth analysis of the balloon catheter market and provides market size (US$ Mn) and Cumulative Annual Growth Rate (CAGR) (%) for the forecast period (2017–2025)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, new product launches or approval, pipeline products, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global balloon catheter market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future product launch, market expansion, and marketing tactics
• The global balloon catheters market report caters to various stakeholders in this industry, including investors, product developers, distributors, healthcare companies, research institutes, medical device companies, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision making through the various strategy matrices used in analyzing the balloon catheters market

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

Small Cell Lung Cancer Therapeutics Market on the basis of diagnosis, types, treatment, drug therapy, and end user - Global Industry Insights, 2025

Small Cell Lung Cancer (SCLC) is malignant form of cancer arising within the lungs. SCLC is characterized by high growth rate, shorter doubling time than the non-small cell lung tumors. SCLC is more responsive to chemotherapy than NSCLC. Small cell lung cancer is highly associated with tobacco, unhealthy food, alcohol, HIV infected, chronic infections or related family history, and physical inactivity. The decrease in smoking is reflected as the substantial decrease in the incidence of SCLC. The symptoms include dyspnea, blood in sputum, weight loss, cough, and debility.

Request to download and view Sample Report: https://www.coherentmarketinsights.com/insight/request-sample/799

Global rise in number of cancer cases expected to support the growth of small cell lung cancer therapeutics market in the near future

According to the American Cancer Society Statistics in 2016, maximum cases of SCLC occur in individuals aged 60-80 years with an estimated global death rate being 30,000 per year. Also, according to the World Health Organization (WHO), lung cancer is the second most prevailing cancer in men and women causing 1.59 million deaths in 2012. The rising prevalence of lung cancer, rise in unhealthy lifestyle, the launch of innovative radiation therapies, and premium priced drugs are the major factors driving the growth of lung cancer therapeutics market. Additionally, rising demand for targeted therapies and platinum-based chemotherapies is likely to have an optimistic impact on the small lung cancer therapeutics market in the forecast period. Also, increasing diagnostic facilities by the government, provision of guidelines to cancer patients by International Healthcare Organizations are the major factors contributing to the rising of small cell lung cancer market. However, expensive treatments, lack of awareness leading to late diagnosis are the major factors restraining the small cell lung cancer market growth.

Platinum derivatives segment accounts for highest revenue share owing to the higher metastasis control rate

The global small cell lung cancer therapeutics market is segmented on the basis of diagnosis, types, treatment, drug therapy, and end user.

On the basis of diagnosis, the global small cell lung cancer therapeutics market is segmented into:

• Fluorescence Bronchoscopy
• Virtual Bronchoscopy

On the basis of types, the global small cell lung cancer therapeutics market is segmented into:

• Oat cancer
• Combined small cell cancer
• Extrapulmonary small cell cancer

On the basis of treatment, the global small cell lung cancer therapeutics market is segmented into:

• Real-time Tumor Imaging
• Radiation Therapy
• Three-dimensional conformal radiation therapy (3D-CRT)
• Intensity modulatedradiation therapy (IMRT)
• Chemotherapy
• Platinum Derivatives
• Topoisomerase Inhibitor
• Surgery

Request to download and view full ToC: https://www.coherentmarketinsights.com/ongoing-insight/toc/799

On the basis of drug therapy, the global small cell lung cancer therapeutics market is segmented into:

• Targeted Therapy Drugs
• Immunotherapy Drugs

On the basis of end user, the global small cell lung cancer therapeutics market is segmented into:

• Hospital
• Hospital Pharmacies
• Drug store
• Ambulatory Surgical Center

Enhanced health care dynamics to boost the Asia Pacific small cell lung cancer market

Regional segmentation of small cell lung cancer therapeutics market by Coherent Market Insights comprises of North America, Europe, Asia Pacific, Latin America, the Middle East and Africa. According to the American Cancer Society Statistics in 2017, around 222,500 cases of lung cancer were diagnosed with 116,990 prevailing in men and 105,510 in women, where small cell lung cancer accounts for 15 percent of lung cancers in the U.S. North America is expected to dominate the market owing to the high developed regions, improved healthcare setup, and growing awareness about healthcare. Asia Pacific is expected to drive the growth of SCLC market in the forecast period owing to the growing awareness of health care, government funding, and the presence of medical requirements for cancer therapeutics in the emerging economies such as India and China.

Browse Research Report At: https://www.coherentmarketinsights.com/ongoing-insight/small-cell-lung-cancer-therapeutics-market-799

Key players in the Small Cell Lung Cancer Therapeutics Market

Key players operating the small cell lung cancer therapeutics market include Elekta AB, Bristol Myers Co., Teva parenteral medicines Inc., Siemens Healthcare GmbH, App pharmaceuticals llc Novartis AG, and Bedford laboratories. 

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.